ScienceDaily - Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy.
Results of this new study are published in the journal Clinical Cancer Research. The results build on work done by the same Yale group in 2005 showing 95 percent effectiveness of a blood test using four proteins.
"The ability to recognize almost 100 percent of new tumors will have a major impact on the high death rates of this cancer," said Mor. "We hope this test will become the standard of care for women having routine examinations."
Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths in the United States and three times more lethal than breast cancer. It is usually not diagnosed until its advanced stages and has come to be known as the "silent killer."
-- Checking In - Feel Great - Lose Weight The HysterSisters January 'Checking In' eMagazine has been published and should be in your email inbox if you are a regi [More]...